TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Invest your way with confidence.

  • ✓Powerful tools & research — at no extra cost
  • ✓Stocks, ETFs, options & more
  • ✓Competitive fees + USD accounts
Stocks/TSX-V/QPT

Quest PharmaTech Inc (QPT : TSX-V)

Common Stock

$0.02

CAD

-0.01 (-33.33%)

Last updated: 2026-10-07

Follow QPT

QPT

Quest PharmaTech Inc

Source:WealthAwesomeWealthAwesome
↓ $0.02 (-42.86%)
30 day period
$0.02$0.03$0.04Jun 18Jul 24Oct 7

Performance

1 Day

+0.00%

1 Week

-33.33%

1 Month

+0.00%

YTD

-42.86%

Key Statistics

Market Cap

$3.38M

52W High

$0.05

52W Low

$0.02

P/E Ratio

0.67

50 Day MA

$0.02

200 Day MA

$0.03

Beta

-0.46

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/7/2026$0.02$0.02$0.02$0.02$0.024,000
10/6/2026$0.03$0.03$0.03$0.03$0.030
10/2/2026$0.03$0.03$0.03$0.03$0.030
9/25/2026$0.03$0.03$0.03$0.03$0.030
9/24/2026$0.03$0.03$0.03$0.03$0.0316,000
9/16/2026$0.03$0.03$0.03$0.03$0.03105,200
8/27/2026$0.02$0.02$0.02$0.02$0.0210,000
8/20/2026$0.02$0.02$0.02$0.02$0.020
8/19/2026$0.02$0.02$0.02$0.02$0.0210,000
8/14/2026$0.02$0.02$0.02$0.02$0.025,500

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on QPT's historical volatility

HistoricalForecast68%95%
C$0.00C$0.07C$0.14C$0.21C$0.28C$0.35TodayJan 27May 15Oct 7Nov 19Jan 2Feb 14

30-Day Vol

252.9%

Annualized

90-Day Vol

224.0%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.02

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.02C$0.01 – C$0.05
60 trading daysC$0.02C$0.01 – C$0.06
90 trading daysC$0.02C$0.00 – C$0.08

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Quest PharmaTech Inc

Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-814,313
Profit Margin
0.00%
ROE (TTM)
19.96%
EPS (Diluted)
0.03
Book Value
0.16

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About QPT

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
RSC-PRockmount Capital Corporation$0.12+380.00%
CTACentaurus Energy Inc$5.08+138.50%
PULPulse Oil Corp$0.01+50.00%
EVNTEventer Technologies Ltd.$1.50+41.51%
VISVisionstate Corp$0.02+33.33%
NCINTG Clarity Networks Inc.$0.42+33.33%
MAPSProstar Holdings Inc$0.18+28.57%
OTMCOreterra Metals Corp.$0.45+27.14%

QPT.V news timeline

10 articles covering QPT.V, most recent first

Latest

Why Quest PharmaTech Inc stock plummeted yesterday

•Stocks

Advertisement